This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Leonard J. Bernestein, MD; Roy G. Geronemus, MD
Laser and Skin Surgery Center of New York 317 E 34th St, Suite 11N New York, NY 10016

Arch Dermatol. 1997;133(1):111-112.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The use of isotretinoin for the treatment of acne has increased over the past 10 years because of its effectiveness and the limited and generally reversible adverse effects associated with it. Although not mentioned in comprehensive reviews of the adverse effects of isotretinoin therapy, hypertrophic scar and keloid formation, both spontaneous and associated with cutaneous injury, are potential risks.¹ Dermatologists and cosmetic surgeons have noted an increased incidence of keloid and hypertrophic scar formation with dermabrasion, excisions, and argon laser treatment.^2,3 These therapies all share local disruption in the structure of collagen in the skin.

The pulsed dye laser (585 nm, 450 microseconds) has been proven safe and effective treatment for various small-diameter vascular processes, such as capillary vascular malformations, hemangiomas, telangiectases, pyogenic granulomas, and angiomas. Using the principles of selective photothermolysis, the pulsed dye laser can deliver high-intensity energy to a target vessel with little to . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?